Hormonal and Reproductive Factors in Relation to Cardiovascular Events in Women with Early Rheumatoid Arthritis

Autor: Antonia Boman, Heidi Kokkonen, Ewa Berglin, Gerd-Marie Alenius, Solbritt Rantapää-Dahlqvist

Publikováno v: Journal of Clinical Medicine; Volume 12; Issue 1; Pages: 208

Hormonal and reproductive factors affect the risk for cardiovascular events (CVE) in the general population. Although the risk of CVE is increased in rheumatoid arthritis (RA), the knowledge about the impact of hormonal factors for CVE in RA is spars

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::428528991d94d1ff060e20cecf30ef15
https://pubmed.ncbi.nlm.nih.gov/36615009

Cardiovascular Risk Factors before Onset of Rheumatoid Arthritis Are Associated with Cardiovascular Events after Disease Onset: A Case–Control Study

Autor: Heidi Kokkonen, Linda Johansson, Hans Stenlund, Solbritt Rantapää-Dahlqvist

Publikováno v: Journal of Clinical Medicine; Volume 11; Issue 21; Pages: 6535

Background: The increased comorbidity and mortality in rheumatoid arthritis (RA) patients are largely due to cardiovascular disease (CVD). Previously, we demonstrated increased frequencies of risk factors for CVD (elevated body mass index (BMI), elev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb1c18d3eb5b8fe8e8378cdba431e2cf
https://doi.org/10.3390/jcm11216535

An increased concentration of receptor activator of nuclear factor kappa-B ligand pre-dates the onset of rheumatoid arthritis

Autor: Lisbeth Ärlestig, Mikael Brink, Linda Johansson, Solbritt Rantapää-Dahlqvist, Heidi Kokkonen

Publikováno v: Rheumatology. 56:2190-2196

RANK ligand (RANKL) is involved in destruction and osteoporosis in RA. In this study, the relationships between RANKL and ACPA, anti-carbamylated protein antibodies (anti-CarP), cytokines and chemokines were analysed in individuals before the onset o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ff58eb0b191b7f783938874370526c7
https://doi.org/10.1093/rheumatology/kex339

Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA.

Autor: Kissel, Theresa, van Wesemael, Tineke J., Lundquist, Anders, Heidi Kokkonen, Atsushi Kawakami, Mami Tamai, van Schaardenburg, Dirkjan, Wuhrer, Manfred, Huizinga, Tom W. J., Scherer, Hans Ulrich, van der Woude, Diane, Rantapää-Dahlqvist, Solbritt, Toes, René E. M., Kokkonen, Heidi, Kawakami, Atsushi, Tamai, Mami, Huizinga, Tom Wj

Publikováno v: Annals of the Rheumatic Diseases; Jan2022, Vol. 81 Issue 1, p141-143, 3p

Thematic stream: inflammatory arthritis (PP01-PP31): PP01. Autoinflammatory Synovitis in Familial Mediterranean Fever is Characterized by Numerous Neutrophils Lacking Myeloperoxidase and Lysozyme, Macrophages, Mast Cells and B Cells, Up-Regulation of Galectin-1, P65 (REL A)/NF-KB and Inos, but not COX-2

Autor: James Cheng-Chung Wei, Tugba Baysak, Aysegul Kucukali Turkyilmaz, Hisashi Yamanaka, Izzet Fresko, Metin Ozgen, Moots Robert, Bunyamin Kisacik, Won Park, Yoshiya Tanaka, Ibrahim Batmaz, Özer Arıcan, Aytul Cakci, Serdar Budak, Jisoo Lee, Kouichi Amano, Rezzan Günaydin, Hatice Bodur, Sema Yilmaz, Yasin Tuluce, Bonnie Vlahos, Derya Kaskari, Tastekin Ebru, Ömür Kayıkçı, Suleyman Yildirim, Chun-Huang Huang, Inita Bulina, Mehmet Tosun, Erten Surkan, Johan Rönnelid, Walter Conca, Ayşegül Koç, Akın Erdal, Vıldan Altunayoğlu Çakmak, Ayhan Dinc, Ajda Bal, Mohammed Mullazehi, Hasan Battal, Sibel Süzen, Sun-Won Park, Daina Andersone, Li-Jie Shiu, Murat Toprak, Gülsüm Emel Pamuk, Çiftdemir Mert, Hyo Jin Choi, Tuba Baykal, Hideto Kameda, Josef S. Smolen, Alif Adlan Mohd Thabit, Masao Nawata, Mehmet Karakoç, Ozcan Hiz, Gulen Hatemi, Chan Hee Lee, Murat Zinnuroglu, Halil Koyuncu, Pierre Tane, Peter Nash, Tsutomu Takeuchi, Mehmet I. Arman, Shunsuke Fukuyo, Filiz Alp, Heselynn Hussein, Zuhal Atılgan, Murat Uludağ, Aylin Rezvani, Huri Ozdogan, Halil Ozkol, Ekin Sen, Yuko Kaneko, Seung Jae Hong, Ji Young Hwang, Constance Hammond, Kılınç Serdar, Eri Satoh, Chang-Hee Suh, Altinay Goksel Karatepe, Umut Kalyoncu, Daisuke Hoshi, Albert Kamanyi, Engin Tezcan, Inta Jaunalksne, Blanche Laure Ndontsa, Hong-Shen Lee, Hui Jen Ding, Mahir Ugur, Marius Mbiantcha, Zeynep Erden, Feride Gogus, Sebahattin Yurdakul, Haner Direskeneli, Altunoglu Alpaslan, Omer Karadag, Sina Esmaeilzadeh, Ruey-Hong Wong, Andrew S Koenig, Pedro Miranda, Bruce Freundlich, Taciser Kaya, Sedat Kiraz, You-Hyun Lee, Şafak Karamehmetoğlu, Ahmet Kiziltunc, Hayato Nagasawa, Erhan Capkin, Takahiko Kurasawa, Nurettin İrem Örnek, Aysegul Jale Saraç, Karel Pavelka, De Silva Vijitha, Deniz Dulgeroglu, Necati Çakır, Emel Ozcan, Remzi Çevik, alternative medicines, Erten Serhat Fuat, Kazim Senel, Ihsan Ertenli, Macfarlane Gary, Omer Nuri Pamuk, Levent Ediz, Salim Dönmez, Tugba Yalcin, El-Metwally Ashraf, Sedat Yilmaz, Suhail Al-Salam, Kentaro Hanami, Heidi Kokkonen, Kerem Gün, Solbritt Rantapää-Dahlqvist, Usta Ufuk, Kemal Nas, Selma Yazıcı, Muammer Muslım Kose, Fatih Baygutalp, Elif Gulcu, Kazuyoshi Saito, Murat Karkucak, Tastekin Nurettin, Ronald Pedersen, Birtane Murat, Telesphore Benoit Nguelefack

Publikováno v: Rheumatology. 50:ii6-ii14

Background: Recent recommendations have established clinical remission ideally or low disease activity (LDA) as therapeutic targets in all patients with rheumatoid arthritis (RA). Controlled studies of biologic agents have primarily assessed treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa7a9816ff3e1405aad7e80d5c280f44
https://doi.org/10.1093/rheumatology/ker097